DCC-3116

DCC-3116 is an orally active ULK1/2 inhibitor. DCC-3116 can promote autophagy in lung cancer cells by inhibiting KRASG12C signaling, thereby inhibiting the proliferation of lung cancer cells and exerting anti-cancer effects.


Cat. No.: EX-A8784	Purity: >98%

	Chemical structure of DCC-3116

For research only, Do not use for Human!

Size	Unit Price (US$)	Stock
100mg	665	In-stock
250mg	1065	In-stock
500mg	1665	In-stock
1g	2365	In-stock
2g	3825	In-stock
5g	6500	In-stock

Send PO to E-mail:order@excenen.com; or Fax:+86 020 81619670

Discount Request


CAS No.	2543673-19-2
Purity	>98%
Formula	C26H36F3N7O2
Mol Weight	535.6049
Appearance	solid
Shelf Life	>2 years if stored properly
Storage	Powder -20℃ 2 years; In solvent -20℃ 1 month;
Shipping	Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Reference:	[1]. Ghazi PC, et al. Inhibition of ULK1/2 and KRAS G12C controls tumor growth in preclinical models of lung cancer. bioRxiv [Preprint]. 2024 Feb 8:2024.02.06.579200.
CoA	CoA of DCC-3116


		Search